In a patient with hyponatremia (serum sodium 133 mEq/L) taking lisinopril 40 mg daily, should I increase dietary sodium intake or adjust the lisinopril therapy?

Reduce or discontinue lisinopril rather than increasing salt intake

In a patient with sodium 133 mEq/L on lisinopril 40 mg daily, you should reduce the lisinopril dose or consider switching antihypertensive agents, not increase salt intake. This mild hyponatremia is likely ACE inhibitor-induced, and increasing dietary sodium contradicts evidence-based hypertension management while failing to address the underlying drug effect.

Why Adjust the ACE Inhibitor

Lisinopril can cause hyponatremia through a rare but documented mechanism: while ACE inhibitors block peripheral conversion of angiotensin I to angiotensin II, circulating angiotensin I enters the brain where it's converted to angiotensin II, stimulating both thirst and inappropriate ADH release 1. Multiple case reports document severe hyponatremia (sodium as low as 101-109 mEq/L) directly attributable to lisinopril, with resolution upon drug discontinuation and recurrence upon rechallenge 1, 2, 3.

The FDA label explicitly addresses this scenario: for heart failure patients with hyponatremia (sodium <130 mEq/L), the recommended starting dose is 2.5 mg daily, not 40 mg 4. While your patient has sodium of 133 mEq/L (just above this threshold), the principle applies—high-dose ACE inhibitor therapy in the setting of borderline-low sodium warrants dose reduction.

Why Not Increase Salt Intake

Current hypertension guidelines strongly recommend restricting dietary sodium to approximately 2 g/day (equivalent to 5 g salt/day) for blood pressure control 5. The 2024 ESC guidelines emphasize that sodium restriction reduces both BP and cardiovascular risk, particularly in hypertensive patients 5. The 2017 ACC/AHA guidelines similarly document that sodium reduction lowers BP by 2-3 mm Hg in hypertensive patients and augments the BP-lowering effects of RAS blocker therapy like lisinopril 6.

Increasing salt intake would:

• Counteract the therapeutic benefit of lisinopril
• Worsen hypertension control
• Increase cardiovascular risk
• Fail to correct drug-induced SIADH physiology

Practical Management Algorithm

1. Reduce lisinopril from 40 mg to 20 mg daily (or 10 mg if sodium remains low)
2. Monitor serum sodium in 3-5 days to confirm improvement
3. If sodium normalizes (≥135 mEq/L), continue reduced dose and monitor BP control
4. If BP becomes uncontrolled at lower lisinopril dose, add a different class antihypertensive (calcium channel blocker, thiazide diuretic with careful sodium monitoring)
5. If sodium remains <133 mEq/L despite dose reduction, discontinue lisinopril entirely and switch to alternative agent (e.g., amlodipine, losartan)

Key Monitoring Points

• Check sodium 3-5 days after any dose adjustment
• Assess volume status (euvolemic vs hypovolemic) to exclude other causes
• Review for other contributing medications (diuretics, SSRIs, NSAIDs) 7
• Ensure adequate dietary protein and solute intake (not excessive salt) 8
• Monitor potassium levels when adjusting ACE inhibitor dose

Common Pitfall to Avoid

Do not simply add salt tablets or liberalize sodium intake while continuing high-dose lisinopril. This approach ignores the drug's role in inappropriate ADH secretion and undermines evidence-based cardiovascular risk reduction through dietary sodium restriction 5, 6. The hyponatremia will likely persist because the underlying mechanism (drug-induced SIADH) remains unaddressed.